Cardinal Health, an American firm in the pharmaceuticals and medical products sector, has been performing remarkably well in the stock market, consistently outpacing overall market gains. The company's stock is forecasted to appreciate further according to JPMorgan Chase & Co. In addition, they're set to expand their operations with a new distribution centre in Fort Worth, Texas. However, there have been mixed actions from investment firms with Gradient Investments LLC selling a significant number of shares while Janney Montgomery Scott LLC and multiple other firms are increasing their holdings. In addition, Cardinal Health recently announced two strategic additions to their portfolio which may positively impact their growth. The company's fourth quarter of fiscal year 2024 results surpassed expectations leading to an increased outlook for fiscal year 2025. The firm achieved a new 52-week high causing some to speculate if the growth can continue. Cardinal Health plans to announce their Q2 FY2025 earnings on January 30. They have also made headlines by acquiring Integrated Oncology Network and launching Kendall SCD SmartFlow™ Compression System. Despite some bearish insider trading signs, the firm's robust performance, strategic expansions and acquisitions forecast a promising future.
Cardinal Health CAH News Analytics from Wed, 14 Aug 2024 07:00:00 GMT to Sat, 25 Jan 2025 17:57:50 GMT -
Rating 7
- Innovation 4
- Information 8
- Rumor 0
